These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8243083)

  • 1. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluoroquinolones--a new and important group of antimicrobial agents].
    Sander J
    Tidsskr Nor Laegeforen; 1992 Jan; 112(3):346-9. PubMed ID: 1553674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone therapy in intensive care unit settings.
    Beam TR
    New Horiz; 1993 May; 1(2):187-93. PubMed ID: 7922402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G; Prosser BL
    Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fluoroquinolones for urinary tract infections: a review.
    Cunha BA
    Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 11. Ofloxacin vs ciprofloxacin: a comparison.
    Nicolau D; Quintiliani R; Nightingale CH
    Conn Med; 1992 May; 56(5):261-3. PubMed ID: 1611900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
    Legout L; Senneville E; Stern R; Yazdanpanah Y; Savage C; Roussel-Delvalez M; Rosele B; Migaud H; Mouton Y
    Clin Microbiol Infect; 2006 Oct; 12(10):1030-3. PubMed ID: 16961643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced and photoinduced DNA damage by quinolones: ciprofloxacin, ofloxacin and nalidixic acid determined by comet assay.
    Sánchez G; Hidalgo ME; Vivanco JM; Escobar J
    Photochem Photobiol; 2005; 81(4):819-22. PubMed ID: 15691228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
    Smelov V; Perekalina T; Artemenko N; Smelova N; Ukleeva G; Gorelov A
    Andrologia; 2005 Jun; 37(2-3):61-4. PubMed ID: 16026425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use.
    Waites K; Rand K; Jenkins S; Yangco B; Brookings E; Gaskins D; Lewis J; Halkias K
    Diagn Microbiol Infect Dis; 1994 Mar; 18(3):181-9. PubMed ID: 7924211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
    Foster MT
    Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
    Greenberg RN; Newman MT; Shariaty S; Pectol RW
    Antimicrob Agents Chemother; 2000 Jan; 44(1):164-6. PubMed ID: 10602739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.